4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-156178
Chief Operating Officer gave up 494 shares (to pay taxes)
- Chief Operating Officer acquired 1,625 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Powala Christopher Chief Operating Officer | 2016-12-18 | Option exercise | +1,625 | 132,059 | D | ||
| Powala Christopher Chief Operating Officer | 2016-12-18 | Shares withheld for taxes | −494 | $31.25 | $15,438 | 131,565 | D |
| Derivatives | |||||||
| Powala Christopher Chief Operating Officer | 2016-12-18 | Option exercise · Restricted Stock Units | −1,625 | 4,875 | D | ||
Loading xslF345X03/doc4.xml…